MétaCan
Menu
Back to cohort

Abstract LB098: Vulnerability of <i>MTAP</i>-deleted nasopharyngeal carcinoma to MAT2A inhibition

2021· article· en· W3178864027 on OpenAlexaff
Yuk Yu Chan, Jeff Bruce, Vivian Wai Yan Lui, Grace Chung, Sai‐Wah Tsao, Ka‐Fai To, Trevor J. Pugh, Kwok Wai Lo

Bibliographic record

VenueCancer Research · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer-related gene regulation
Canadian institutionsUniversity of TorontoPrincess Margaret Cancer CentreUniversity Health Network
Fundersnot available
KeywordsCDKN2ACancer researchBiologySynthetic lethalityCancerNasopharyngeal carcinomaGeneCopy-number variationGeneticsMedicineGenomeInternal medicineRadiation therapyDNA repair

Abstract

fetched live from OpenAlex

Abstract Nasopharyngeal carcinoma (NPC) is an EBV-associated cancer prevalent in Southern China and Southeast Asia. We have generated a comprehensive genomic profile of NPC using whole-genome sequencing (WGS) and established a catalogue of somatic alterations of this EBV-associated cancer. In addition to the significantly mutated genes reported in previous WES studies, our WGS study revealed recurrent structural variants (SVs) and copy number variants (CNVs) driving key oncogenic pathways, including cell cycle, NF-kappaB and TGF-beta signaling. While immediately druggable gene aberrations (e.g. PIK3CA mutations and FGFR3-TACC3 fusions) are found in only ~3-5% of NPC, a synthetic lethality-based target, homozygous deletion of MTAP defined by fine-mapping of CDKN2A/CDKN2B deletion breakpoints at chromosome 9p21.3 was frequently detected (34%). Notably, the study has also revealed mutual exclusivity among tumors with MTAP deletion and TP53 alterations (p=0.022). Loss of MTAP has further been validated in a cohort of advanced and recurrent tumors (16/50, 32%) by FISH analysis and immunohistochemistry staining. The high prevalence and clonal nature of MTAP deletion in NPC implicate synthetic lethal targeting of MTAP-deleted tumors as a potential precision treatment for NPC patients. Using a CRISPR-based MTAP-knockout cell line and MTAP-deleted patient derived xenograft (PDX), we revealed that MAT2A and PRMT5 inhibition selectively suppressed growth of MTAP-deleted NPC. Treatment with MAT2A inhibitor, FIADS-5, led to depleted PRMT5 activity and reduced symmetric arginine methylation (SAMe) in these in vitro and in vivo NPC models. In addition to selective growth inhibition, MAT2A inhibition also targeted various unique oncogenic properties in NPC. The FIADS-5 treatment was shown to induce TP53 and BAX expression, cellular differentiation and keratinization in these MTAP-deleted NPC. Our findings demonstrated the translational potential of targeting MTAP-deletion in this EBV-associated epithelial cancer. Citation Format: Yuk Yu Chan, Jeff P. Bruce, Vivian W.Y. Lui, Grace T. Y. Chung, Sai-Wah Tsao, Ka-Fai To, Trevor J. Pugh, Kwok-Wai Lo. Vulnerability of MTAP-deleted nasopharyngeal carcinoma to MAT2A inhibition [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB098.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.371
Teacher spread0.326 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicCancer-related gene regulationFrench-language works237,207